November 17, 2012
MAKO Surgical's (Nasdaq: MAKO ) story so far has been one as full of questions as it is potential. Motley Fool analyst Brenton Flynn, for one, certainly has his reservations around some aspects of the stock. Specifically, he wonders if the market for partial knees will really materialize as forecast. However, if you ask the two MAKO insiders who recently made decent sized purchases of MAKO stock, the response would likely be along the lines of, "Is the Pope Catholic?"
Follow along in the video below as Brenton outlines the news in more detail.
The recent market sell-off of MAKO Surgical shares has many wondering whether the potential growth prospects of the robotic surgery company make this stock a buy or a stock to stay away from. To answer this question, Fool.com analyst and MAKO expert David Meier has authored a premium research report covering all of the must-know details on the company, including key areas to watch and risks looming in the future. As an added bonus, David will keep you informed with a full year of updates and guidance on MAKO Surgical as news breaks. Click here now to learn more and start reading.